WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark MYOGENDYS was filed as Word mark on 10/15/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1585602 |
| Countries | 
|
| Base trademark |
No. 88886717,
April 24, 2020
|
| Application date | October 15, 2020 |
| Expiration date | October 15, 2030 |
Trademark owner
215 First Street
Cambridge MA 02142
US
Cambridge MA 02142
US
Trademark representatives
3724 Benson Drive
Raleigh NC 27609
US
goods and services
05
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations based on
morpholino oligomer technology platform for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders, and for the regulation of protein
production; pharmaceutical preparations that modulate rna
expression for the treatment of neuromuscular diseases and
disorders, muscular dystrophies, central nervous system
diseases and disorders, genetic diseases and disorders, and
for the regulation of protein production; gene therapy
products, namely, gene delivery pharmaceuticals;
pharmaceutical preparations for gene therapy, gene editing,
and genome editing; gene therapy products for the treatment
of neuromuscular diseases and disorders, muscular
dystrophies, central nervous system diseases and disorders,
genetic diseases and disorders; biological preparations for
the treatment of neuromuscular diseases and disorders,
muscular dystrophies, central nervous system diseases and
disorders, genetic diseases and disorders; viruses, viral
vectors and viral constructs, all of the foregoing used as
delivery agents, for the treatment of neuromuscular diseases
and disorders, muscular dystrophies, central nervous system
diseases and disorders, genetic diseases and disorders;
pharmaceutical preparations, biological preparations and
gene therapy products in the nature of pharmaceutical and
biological preparations for the treatment of genetic
disorders and diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 10, 2022 | 2022/48 Gaz | US | RAW: Total Ceasing Effect |
| October 13, 2022 | 2022/41 Gaz | KR | Rejection |
| September 21, 2022 | 2022/40 Gaz | IS | Rejection |
| August 5, 2022 | 2022/32 Gaz | CA | Rejection |
| July 7, 2022 | 2022/27 Gaz | MX | Rejection |
| May 10, 2022 | 2022/19 Gaz | KR | Rejection |
| March 9, 2022 | 2022/10 Gaz | CH | Rejection |
| March 3, 2022 | 2022/9 Gaz | NO | Rejection |
| February 28, 2022 | 2022/9 Gaz | TR | Rejection |
| February 10, 2022 | 2022/6 Gaz | JP | Rejection |
| November 16, 2021 | 2021/46 Gaz | BR | Rejection |
| October 11, 2021 | 2021/41 Gaz | IN | Rejection |
| August 18, 2021 | 2021/33 Gaz | GB | Rejection |
| August 6, 2021 | 2021/32 Gaz | CN | Rejection |
| June 28, 2021 | 2021/26 Gaz | RU | Rejection |
| October 15, 2020 | 2021/12 Gaz | US | Registration |
ID: 141585602